{"version":"1.0","type":"link","title":"Neoadjuvant Combination Therapy with Tyrosine Kinase and Immune Checkpoint Inhibitors in Anaplastic Thyroid Cancer: A Single-Center, Real-World Experience.","author_name":"Song Y 외","author_url":"https://prs-insight.online/author/Song%20Y","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/139002","thumbnail_width":1200,"thumbnail_height":630}